GO:0030198 | Extracellular matrix organization | < 0.001 | bta04974 | Protein digestion and absorption | < 0.001 |
GO:0001836 | Release of cytochrome c from the mitochondria | 0.001 | bta04510 | Focal adhesion | < 0.001 |
GO:0097192 | Extrinsic apoptotic signaling pathway in the absence of ligand | 0.003 | bta04151 | PI3K-Akt signaling pathway | < 0.001 |
GO:0071456 | Cellular response to hypoxia | 0.025 | bta04512 | ECM–receptor interaction | < 0.001 |
GO:0051781 | Positive regulation of cell division | 0.034 | bta04926 | Relaxin signaling pathway | 0.001 |
GO:0045893 | Positive regulation of transcription, DNA-templated | 0.035 | bta05165 | Human papillomavirus infection | 0.001 |
GO:0060070 | Canonical Wnt signaling pathway | 0.036 | bta05222 | Small cell lung cancer | 0.001 |
GO:0051897 | Positive regulation of protein kinase B signaling | 0.037 | bta05200 | Pathways in cancer | 0.005 |
GO:0010595 | Positive regulation of endothelial cell migration | 0.043 | bta01521 | EGFR tyrosine kinase inhibitor resistance | 0.009 |
GO:0008630 | Intrinsic apoptotic signaling pathway in response to DNA damage | 0.049 | bta05205 | Proteoglycans in cancer | 0.018 |